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DNA methylation refers to the conversion of 
cytosine to 5-methylcytosine (5mC) by the activity of 
the DNA methyltransferase enzymes (namely DNMT1, 
DNMT3A and DNMT3B). The preservation of the 
epigenetic code introduced by DNA methylation is not 
only necessary for shaping proper transcriptional 
networks of each specific cell type but also for assuring 
genomic stability [1]. During development, cellular 
differentiation and senescence, profound changes of 
DNA methylation patterns occur, allowing the 
repression or activation of specific genes through 
hypermethylation or demethylation of their promoters 
and/or distal regulatory sequences [2,3]. Chronological 
alteration of DNA methylation patterns is a well-
recognized hallmark of aging, identifiable in most of 
human tissues [4]. Notably, similar epigenetic 
alterations are typical of pathological conditions highly 
associated with age, including cancer and neuro-
degeneration [5,6]. The alterations of DNA methylation 
in aging are characterized by the co-occurrence of DNA 
demethylation and hypermethylation events. The 
genome undergoes a global loss of methylation together 
with the acquisition of site-specific hypermethylation, 
which prevalently concerns the CpG islands (CGI) [6–
8]. Notably, the presence of specific hot-spots of age-
associated differential methylation led to the possibility 
of exploiting DNA methylation as a biomarker of 
biological aging [4,8,9]. 
 
The transcriptional deregulation of DNMT enzymes has 
been proposed as one of the potential causes of the 






















Impairment of DNMT transcription and/or activity 
could result from interaction with environmental 
factors, including life-style choices and dietary habits 
[8,10]. 
 
The recent discovery of 5-hydroxymethylcytosine 
(5hmC) has, however, increased the complexity of 
epigenetic events influencing DNA methylation 
patterns. 5hmC derives from the oxidation of 5mC by 
the action of the Fe2+- and 2-oxoglutarate-dependent 
dioxygenases TET1, TET2 and TET3 [11,12]. TET 
enzymes show distinct and overlapping functions in 
terms of stage- and organ-specific functions [11,12] as 
well as in patterning the distribution of 5mC and 5hmC 
signals in the genome [13]. Global levels of 5hmC are 
highly variable in human tissues. Brain represents the 
tissue with the highest content of 5hmC [11,14]. 
Compelling evidence indicates that 5hmC has a dual 
role on the genome, acting both as an epigenetic mark 
and an intermediate of DNA demethylation. 
Consistently, 5hmC is now considered as “the sixth 
base” of genome (with 5mC being “the fifth base”) 
playing important functions in the regulation of 
transcription. On the other hand, 5hmC is also pivotal 
for starting active DNA demethylation processes 
[11,12]. In fact, all TET enzymes can catalyze the 
sequential oxidations of 5mC initially into 5hmC and 
then into 5-formylcytosine (5fC) and 5-carboxyl-
cytosine (5caC) [15], thus triggering the substitution of 
5mC derivatives with unmethylated cytosines by DNA 
repair mechanisms. The base excision repair (BER) 
pathway, through the action of the thymine DNA 
glycosylase (TDG), seems to be largely involved in the 
removal of 5fC and 5caC from DNA [16]. In addition, 
ABSTRACT 
 
Gradual  changes  in  the DNA methylation  landscape occur  throughout aging virtually  in all human  tissues. A
widespread  reduction  of  5‐methylcytosine  (5mC),  associated  with  highly  reproducible  site‐specific
hypermethylation,  characterizes  the  genome  in  aging.  Therefore,  an  equilibrium  seems  to  exist  between
general and directional deregulating events concerning DNA methylation controllers, which may underpin the
age‐related epigenetic changes. In this context, 5mC‐hydroxylases (TET enzymes) are new potential players. In
fact, TETs catalyze  the stepwise oxidation of 5mC  to 5‐hydroxymethylcytosine  (5hmC), 5‐formylcytosine  (5fC)
and  5‐carboxylcytosine  (5caC),  driving  the  DNA  demethylation  process  based  on  thymine  DNA  glycosylase
(TDG)‐mediated DNA  repair pathway. The present paper  reports  the expression of DNA hydroxymethylation
components, the  levels of 5hmC and of  its derivatives  in peripheral blood mononuclear cells of age‐stratified
donors  recruited  in  several  European  countries  in  the  context  of  the  EU  Project  ‘MARK‐AGE’.  The  results
provide evidence  for an age‐related decline of TET1, TET3 and TDG gene expression along with a decrease of
5hmC and an accumulation of 5caC. These associations were  independent of confounding variables,  including
recruitment  center,  gender  and  leukocyte  composition.  The  observed  impairment  of  5hmC‐mediated  DNA
demethylation pathway in blood cells may lead to aberrant transcriptional programs in the elderly. 
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the TET-mediated oxidations of 5mC may also lead to 
passive DNA demethylation, as DNMTs fail to 
recognize 5hmC, 5fC or 5caC during the replication-
associated process of DNA methylation maintenance 
[17,18]. Deregulation of TET enzymes, followed up by 
either DNA repair or DNA replication, may contribute 
to the anomalous DNA methylation patterns observed in 
aging via the 5hmC intermediate. However, efforts 
addressed to this topic are still very limited and focused 
on brain tissues, where an increase of 5hmC levels has 
been mainly observed with age [19,20]. 
 
In the present work, the association of 5hmC with aging 
has been investigated in peripheral blood mononuclear 
cells (PBMC), an easily accessible biological sample 
whose DNA methylation dynamics with age have been 
largely characterized [7]. In particular, the expression of 
members of the DNA demethylation machinery, 
including TET enzymes and TDG, as well as the levels 
of 5hmC and its derivatives have been evaluated in 
individuals aged 34-74 years enrolled for the MARK-
AGE Project, an Europe-wide cross-sectional 
population study aimed at the identification of 

































The sample of study consisted of PBMC from 188 
volunteers enrolled in eight European countries (i.e. 
Austria, Belgium, Finland, Germany, Greece, Italy, The 
Netherlands, Poland) covering the age range between 34 
and 74 years. The population was stratified into three 
age groups (i.e. 34-48; 49-65; 66-74) sharing 
comparable sample size and gender composition. 
However, female representation was slightly larger than 
males in the 34-48 age class. In all age classes the mean 
value of the body mass index (BMI) was largely below 
30 kg/m2, which is the threshold for obesity. Moreover, 
in agreement with literature data, the BMI appeared to 
increase with age indicating that the population 
analyzed was representative of a physiological aging 
process. Another feature given in Table 1 includes self-
reported smoking status of the population studied, 
which was almost similar between age groups. About 
the half of the subjects had never smoked while the 




































 ALL Age groups 
 
N 188 67 60 61 
Age (y) Range 34-74 34-48 49-65 66-74 Mean 55.6 40.4 57.5 70.5 
Gender 




Mean ± SD 25.8 ± 4.5 24.9 ± 4.2 25.8 ± 4.5 26.7 ± 4.7 
< 25 50 (93) 60 (40) 53 (32) 35 (21) 
25 to 30 35 (66) 24 (16) 30 (18) 52 (32) 




never 52 (97) 58 (39) 46 (28) 49 (30) 
former 33 (63) 21 (14) 37 (22) 44 (27) 
current 15 (28) 21 (14) 17 (10) 7 (4) 
Country 
% (N) 
Austria 14 (26) 13 (9) 15 (9) 13 (8) 
Belgium 10 (19) 1 (1) 7 (4) 23 (14) 
Italy 24 (45) 40 (27) 18 (11) 11 (7) 
Finland 5 (9) 1 (1) 5 (3) 8 (5) 
Germany 16 (31) 12 (8) 27 (16) 11 (7) 
Greece 16 (29) 22 (15) 15 (9) 8 (5) 
The Netherlands 6 (12) 0 (0) 3 (2) 16 (10) 
Poland 9 (17) 9 (6) 10 (6) 8 (5) 
    1 Values are mean ± SD and percentage (number). (y)=years. 
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Characterization of data values 
 
The parameters analyzed were tested for normal 
distribution and most of them failed to pass the 
Kolmogorov-Smirnov and Shapiro-Wilk normality tests 
(data not shown). Due to skewness and high kurtosis of 
non-transformed values, data were log-transformed but, 
also in this case, parameters did not show normal 
distribution. As such, both parametric and non-
parametric tests were applied to verify the robustness of 
correlations and the results of group comparisons. The 
generalized linear model (GLM) analysis was 
performed to investigate the influence of covariates and 
multiple confounding factors, including recruitment 
center, gender and the lymphocyte to monocyte 
(lympho/mono) ratio. The latter was taken into account 
as PBMC are a mixed cell population, mainly 
characterized by lymphocytes and monocytes, and the 
relative composition of each cell type has been 
demonstrated to affect methylation studies [10,23]. 
Furthermore, to rule out the possibility of misleading 
interpretation of data due to potential batch effects, the 































transformed values adopting two diverse correction 
procedures: (1) by using default settings; (2) by 
attempting to retain age and gender differences [10]. 
 
Age-dependent expression of TET and TDG genes in 
PBMC 
 
The assessment of TET1, TET2, TET3 and TDG genes 
mRNA expression was performed by RT-qPCR. 
Spearman’s correlation analysis yielded a highly 
significant negative linear association between TET1 
expression and age for both non-transformed and log-
transformed values, which was even more pronounced 
after batch effect correction. Pearson’s correlation 
analysis also supported a significant linear decline of 
TET1 transcript with age (Fig. 1, upper panels). No 
association with age was observed for TET2 expression 
(Fig. 2), whose values showed high variance. According-
ly, cluster analysis performed on TET2 data identified 
two subgroups separated around the 75th percentile value 
(Supplementary Fig.1A and B), where the one with 
higher TET2 levels showed a median value six times 
































Figure  1.  Age‐related  changes  of  TET1  mRNA  levels  in  PBMC.  Upper  panels  show  scatter  plots  representing  the  linear
correlation between TET1 mRNA levels and age in PBMC calculated from (A1) non‐transformed TET1 data, (B1) log‐transformed TET1
data,  (C1) batch‐corrected TET1 data,  (D1) batch‐corrected TET1 data retaining age and gender differences. Parametric  (Pearson r)
and non‐parametric  (Spearman’s  ρ)  correlation  coefficients  and  statistical  significance  are  given  above each  graph.  Lower panels
show bar graphs reporting  the expression  levels of TET1 gene  in  three different age classes calculated  from  (A2) non‐transformed
TET1 data, (B2) log‐transformed TET1 data, (C2) batch‐corrected TET1 data, (D2) batch‐corrected TET1 data retaining age and gender
differences.  Boxplots  show  the median,  the  interquartile  range  (boxes)  and  the  5–95%  data  range  (whisker  caps).  Comparisons
between groups were performed by the Kruskal‐Wallis test followed by post‐hoc Bonferroni test (*P < 0.05; **P < 0.01). (y)= years. 
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two subgroups of TET2 expression data were correlated 
separately to age but, even in this case, no association 
was obtained (Supplementary Fig.1C and D). Regarding 
TET3, both parametric and non-parametric analyses 
revealed a negative correlation with age, which was 
even more evident after the removal of batch effects 
(Fig. 3, upper panels). The relationship of TET1 and 
TET3 genes with age was further tested against gender 
and center by bootstrapped regression analysis 
(Supplementary Table 1 and 2). Notably, the negative 
correlation of TET1 and TET3 with age was retained in 
all conditions, indicating that even if an influence of 
gender and geographical origin could exist, age affects 
their expression almost independently. The same 
analyses confirmed the lack of association with age of 
both TET2 and TET2 expression clusters independently 
of gender and recruitment center (data not shown). 
 
Additional evidence of a link between aging and TETs 
gene expression was obtained by stratifying samples 
into three age classes. The age group including the 
younger individuals (34-48y) showed significantly 
higher expression of both TET1 and TET3 compared to 
































This was even more evident after correction of batch 
effects when preserving gender and age differences 
(Fig. 1 and 3, lower panels). Thereafter, more detailed 
analyses were adopted to determine the influence of 
covariates and multiple confounding factors including 
recruitment center, gender and lympho/mono ratio on 
the age group differences. In particular, GLM analysis 
revealed that the TET1 expression difference between 
age groups resisted the confounding factors in the case 
of batch effect corrections (Supplementary Table 3). 
Due to the notable impact of leukocyte composition of 
PBMC on TET1 expression, bootstrapping-coupled 
regression analysis was performed for TET1 and age 
stratifying for the lympho/mono ratio. This analysis 
definitively demonstrated that age independently 
affected TET1 expression (Supplementary Table 4). 
Similar approaches confirmed that the expression of 
TET2 was not associated with age but rather affected by 
lympho/mono ratio (Fig. 2, lower panels, and 
Supplementary Table 5). Regarding TET3 expression, it 
was sensitive to all tested variables, especially to 
gender, but none of them affected the observed 

































Figure 2. Age‐related  changes of  TET2 mRNA  levels  in PBMC. Upper  panels  show  scatter  plots  representing  the  linear
correlation between TET2 mRNA  levels and age  in PBMC calculated  from  (A1) non‐transformed TET2 data,  (B1)  log‐transformed
TET2  data,  (C1)  batch‐corrected  TET2  data,  (D1)  batch‐corrected  TET2  data  retaining  age  and  gender  differences.  Parametric







































The analysis of TDG expression revealed a slight 
negative correlation with age (Fig. 4, upper panels), 
which was also maintained after batch effect 
corrections. Regression analysis with bootstrapping 
supported the decline of TDG with increasing age 
(Supplementary Table 7), which probably was too 
moderate for being endorsed by the analysis by age 
classes (Fig. 4, lower panels). GLM analysis uncovered 
an influence of the recruitment center on TDG 
expression (Supplementary Table 8). 
 
DNA methylation analysis of TET1 and TDG genes 
 
Focal DNA hypermethylation events are part of age-
associated changes of DNA methylation patterns and, if 
occurring on transcriptional regulatory regions, they 
may lead to down-regulation of gene expression [8]. 
DNA methylation-mediated control of the genes 
showing age-related decline has only been demonstrated 
for TET1 and TDG. In particular, hypermethylation of 
TET1 and TDG CGIs but also of the TET1 CGI 3'-shore 
has been associated with transcriptional repression [24–

































platform was used to determine the DNA methylation 
profile of TET1 and TDG genes in young (34-41y) and 
old (69-74y) individuals. The analysis of the TET1 CGI 
revealed a slight but significant hypermethylation of 
some CpGs in the elderly group (Fig. 5). On the 
contrary, no other CpGs, neither in the TET1 CGI 3'-
shore nor in the TDG CGI, showed any statistically 
significant change of the DNA methylation levels 
(Supplementary Fig. 2). 
 
Content of 5hmC and its derivatives in PBMC in 
aging 
 
Analysis of global content of 5hmC, performed by dot 
blot assay with specific antibodies to 5hmC, showed 
that its levels decreased linearly with age as 
demonstrated by Pearson’s and Spearman’s correlations 
for both non-transformed and log-transformed data. 
This result was even more evident after correction of 
batch effects (Fig. 6, upper panels). Regression analysis 
performed by using bootstrap resampling stratified for 
gender and recruitment center supported the solid 
negative association between age and 5hmC content 
Figure  3.  Age‐related  changes  of  TET3 mRNA  levels  in  PBMC.  Upper  panels  show  scatter  plots  representing  the  linear
correlation between TET3 mRNA levels and age in PBMC calculated from (A1) non‐transformed TET3 data, (B1) log‐transformed TET3
data,  (C1) batch‐corrected TET3 data,  (D1) batch‐corrected TET3 data retaining age and gender differences. Parametric  (Pearson r)
and non‐parametric  (Spearman’s  ρ)  correlation  coefficients  and  statistical  significance  are  given  above each  graph.  Lower panels
show bar graphs reporting  the expression  levels of TET3 gene  in  three different age classes calculated  from  (A2) non‐transformed
TET3 data, (B2) log‐transformed TET3 data, (C2) batch‐corrected TET3 data, (D2) batch‐corrected TET3 data retaining age and gender
differences.  Boxplots  show  the median,  the  interquartile  range  (boxes)  and  the  5–95%  data  range  (whisker  caps).  Comparisons
between groups were performed by the Kruskal‐Wallis test followed by post‐hoc Bonferroni test (*P < 0.05; **P < 0.01). (y)= years. 
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(Supplementary Table 9). Confirmatory results were 
also obtained when samples were stratified in age 
classes. In fact, the group of younger individuals (34-
48y) was significantly different from the remaining two 
groups (49-65y and 66-74y) (Fig. 6, lower panels). 
GLM analysis confirmed the negative association of 
5hmC with age and also revealed a potential impact of 
recruitment center with no consequences on the age-
dependent reduction of 5hmC though (Supplementary 
Table 10). 
 
As TET enzymes are also responsible of the conversion 
of 5hmC into 5fC and then 5caC, which are considered 
DNA demethylation intermediates, their levels were 
also determined by dot-blot analysis. Due to the low 
genomic content of 5fC and 5caC and the limited 
amount of DNA available, DNA from multiple samples 
was pooled into 9 groups of increasing age. This 
analysis confirmed the decreasing trend of 5hmC with 
aging and revealed an accumulation of 5caC in older 
ages. By contrast, the levels of 5fC appeared to be 
comparable between groups (Fig. 7). Notably, 
correlation analyses showed a significant negative 
association between 5hmC and 5caC levels (Pearson r: -































Correlation between components of DNA 
demethylation machinery, 5hmC levels and other 
epigenetic enzymes 
 
A putative correlation between the expression of TET1-
3 and TDG and the levels of 5hmC was investigated. A 
slight significant positive correlation was only detected 
by non-parametric test between TET1 expression and 
5hmC levels after batch effect correction (Table 2). 
Further correlation analyses were then performed to 
trace back a possible co-regulative network involving 
TET genes, TDG and other epigenetic factors 
functionally related to DNA methylation/demethylation 
pathways. In particular, data from the same subset of 
PBMC samples were available for DNA 
methyltransferases DNMT1 and DNMT3B and for 
poly(ADP-ribose) polymerases PARP1 and PARP2. The 
most evident associations were obtained for TET1, 
which exhibited significant positive correlations with 
TDG, DNMT1, DNMT3B, along with PARP1 and 
PARP2. A strong correlation was also found between 
TDG and PARP2. Notably, correlations between these 
variables were significant after both parametric and 
non-parametric tests, with or without batch effect 































Figure  4. Age‐related  changes  of  TDG mRNA  levels  in  PBMC. Upper  panels  show  scatter  plots  representing  the  linear





differences. Boxplots  show  the median,  the  interquartile  range  (boxes) and  the 5–95% data  range  (whisker  caps). Comparisons
between groups were performed by the Kruskal‐Wallis test followed by post‐hoc Bonferroni test. (y)= years. 
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the one between TET3 and TET2 or PARP1, or between 
this latter and TDG, were not confirmed by either test or 
they only emerged after the removal of batch effects 
(Table 2 and 3). 
 
Analysis of clinical variables associated with the 
bimodal distribution of TET2 mRNA levels 
 
Apart from data on TET2 gene expression, all other 
parameters investigated displayed a homogenous 
distribution of values and a similar variance. In fact, 
TET2 values split the samples into two main subgroups, 
whose classification in high and low TET2 expression 
classes was not ascribable to demographic characteris-
tics including gender, age or the country of origin 








































The availability of a large set of clinical parameters for 
the individuals enrolled prompted the investigation of the 
possible sources underlying the high variability of TET2 
expression. For this purpose, a decision tree analysis was 
performed, which identified the serum levels of alanine 
aminotransferase (ALT) as the most important factor 
influencing TET2. Minor subgroups were determined on 
the basis of serum glucose and urine creatinine concen-
trations. In particular, individuals showing high TET2 
expression also had elevated ALT and intermediate 
glycaemia while about one third of them showed lower 
levels of urine creatinine concentrations (Fig. 8). How-
ever, as the subdivision of TET2 values based on serum 
glucose levels fell within the normoglycemic range and 
the low creatinine subgroup concerned very few 
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was examined further. In particular, GLM analysis, with 





















































covariates, definitively confirmed the positive association 










































































































































































































































































































***   *** 
0.299 
0.000 
Log-transformed Log-transformed (batch corr.) 
Log-transformed 
(batch corr_age;gender) 
The  linear  association  between  parameters  was  calculated  using  parametric  (Pearson  r)  and  non‐parametric  (Spearman’s  ρ)  correlation 
coefficients considering Log‐transformed data; Log‐transformed data after batch effect correction (batch corr.); and Log‐transformed data after 



















































Although the discovery of 5hmC is quite recent 
compared to that of other epigenetic modifications, 
relevant achievements have been rapidly reached about 
its function and that of the TET family enzymes in 
development, stem cell biology and disease as well 
[11,12]. In fact, the interest in “the sixth base” of DNA 
is continuously growing as the impaired formation of 
5hmC occurs in several pathologies such as cancer and 













































5hmC levels have been ascribed to genetic or 
transcriptional faults concerning TET genes. In cancer, 
the global loss of 5hmC has been frequently associated 
with TET2 somatic mutations in leukemia [28,29] or 
with TET1 silencing in solid tumors [25,26]. As far as 
neurodegenerative disorders are concerned, loss of 
5hmC has been described in the striatum and cortex of 
Huntington's disease brains [30] and in PBMC from 
multiple sclerosis patients [31]. In contrast, mainly 
accumulation of 5hmC seems to characterize cerebral 
cortex and hippocampus of Alzheimer's disease patients 
Figure 6. Age‐related changes of 5hmC  levels  in PBMC. Upper panels show   scatter  plots representing  the   linear correlation 
between 5hmc levels and age in PBMC calculated from (A1) non‐transformed 5hmC data, (B1) log‐transformed 5hmC data, (C1) batch‐
corrected  5hmC  data,  (D1)  batch‐corrected  5hmC  data  retaining  age  and  gender  differences.  Parametric  (Pearson  r)  and  non‐
parametric  (Spearman’s  ρ)  correlation  coefficients  and  statistical  significance  are  given  above  each  graph.  Lower  panels  show  bar
graphs  reporting  the  levels  of  5hmC  in  three  different  age  classes  calculated  from  (A2)  non‐transformed  5HMC  data,  (B2)  log‐
transformed  5hmC  data,  (C2)  batch‐corrected  5hmC  data,  (D2)  batch‐corrected  5hmC  data  retaining  age  and  gender  differences.
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[5,32]. It is noteworthy that the hippocampus in aging 
also shows increasing levels of 5hmC [19,20] and that 
TET2 mutations have been found associated with older 
age [28,29]. In addition, together with Alzheimer's 
disease and cancer, other age-associated pathological 
states, including diabetes [33] and atherosclerosis [34] 
are characterized by deregulated 5hmC levels. 
Therefore, a partial contribution of age-associated 
epigenetic changes to the onset of those pathologies is 
conceivable. 
 
In the present work, the age-associated expression in 
blood cells of pivotal enzymes involved in active DNA 









































recruited from the general population of eight European 
countries. The data indicated that TET1 and TET3 gene 
expression in PBMC undergo a linear decrease with 
aging whereas TET2 was not influenced. Evidence of 
TET enzymes down-regulation in aging has been 
previously reported in human epidermis for TET1 [35], 
in mouse liver for Tet3 [36] and in human T-cells for 
both genes [37]. All together these observations indicate 
that altered level of 5mC-hydroxylases could be a 
common feature of aging in multiple tissues. 
 
The investigation of demographic variables that could 
potentially affect the expression of TET genes in PBMC 
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and country of origin. By contrast, expression of TET1 
was influenced by cell type composition of PBMC 
samples. In particular, high expression of TET1 was 
associated with high lympho/mono ratio (data not 
shown), which is in agreement with the low TET1 levels 
observed in human monocytes and monocyte-derived 
dendritic cells [38]. The effect of distinct leukocyte 
populations in epigenetic studies based on blood sample 
analyses have also been reported for DNA methylation 
patterns [23] and for the expression of the maintenance 
methyltransferase DNMT1 as well [10]. Nevertheless, in 
the case of TET1 and TET3, age basically acts as an 
independent variable with respect to the effect of other 
confounding factors. 
 
Hypermethylation of the promoter-associated CGI and 
of the 3'-shore of TET1 gene is responsible of its 
silencing in cancer [24–26]. Moreover, aberrant 
methylation of the TET1 CGI 3'-shore was also 
observed in persons affected by Down Syndrome, a 
disease with several characteristics of accelerated aging, 
but no information about the transcriptional outcome of 
this event is available yet [39]. The possible physio-
logical changes in the DNA methylation profile of TET1 






























The results showed hypermethylation of few CpGs 
within TET1 CGI in the elderly group. The low 
differential methylation level observed between young 
and old people groups does not permit to conclude that 
the age-dependent decrease of TET1 in PBMC is 
caused by the hypermethylation of this region, but it 
raises the possibility that such epigenetic change 
pertains to a specific subpopulation of PBMC. 
 
Even though TET2 expression did not show any 
particular trend with age, this parameter was interesting 
as more than a fifth of all samples had remarkable high 
expression levels. However, this peculiar feature of 
TET2 gene could not be traced back to gender and/or 
recruitment center. On the other hand, the examination 
of several variables, mainly including clinical 
laboratory parameters, revealed a potential influence of 
elevated levels of serum ALT. Notably, the values of 
ALT showing association with high TET2 levels were 
mainly below the upper limit for conventional 
“normal” ALT range but quite over the one of the 
updated “healthy” ALT range calculated on 
individuals having other clinical parameters within 






































Square df Sig. 
(Intercept) 142.9180 1 < 0.001 
Center 16.747 7 0.019 
Gender 26.074 1 < 0.001 
Age groups 2.238 2 0.327 
Lympho/mono 3.356 1 0.067 
TET2 class 10.778 1 0.001 
†Analysis was performed by GLM using linear model with identity 
link‐function  considering  as  dependent  variable: Alanine  amino‐
transferase.  Model:  (Intercept),  center,  gender,  age  groups, 
lympho/mono (used as continuous variable); TET2 classes. 
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Increased ALT levels are generally associated to hepatic 
injury and can depend on various causes including 
hepatitis virus infections, hepatic steatosis but also 
medications, thyroid disorders and celiac disease [41]. 
The origin of elevated ALT levels was thus difficult to 
be determined in the examined population based on the 
available clinical data of donors. Nevertheless, the 
interesting TET2 up-regulation in PBMC, associated 
with ALT levels, could indicate the need of TET2 
immunological functions [42] for orchestrating a 












































The transcriptional analyses revealed that also the 
expression of TDG, which initiates the removal of 5fC 
or 5caC through the BER pathway [16] underwent a 
slight decline with age in PBMC. TDG is historically 
known for its anti-mutagenic role in BER, as it removes 
the thymine moiety from the G:T mismatches, besides 
being the main DNA glycosylase involved in active 
DNA demethylation [43]. It is known that impairments 
of the DNA damage response are implicated in aging 
process. In fact, genetic defects of genes belonging to 













































Decision  tree  analysis  was  performed  to  identify  potential  variables  responsible  of  TET2  gene  bimodal
distribution. Apart from demographic characteristics, several clinical biochemistry parameters were included.
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pair systems cause progeroid syndromes, characterized 
by premature aging phenotypes [44]. Notably, also age-
related dysfunctions of BER enzyme expression and/or 
activity have been found in several tissues but no 
specific information about TDG is available so far 
[45]. 
 
The decline of TET1 and TET3 transcripts with age 
coincided with the reduction of the global levels of 
5hmC. However, only a weak association between TET1 
and 5hmC was evidenced suggesting that the drop of 
DNA hydroxymethylation with age is most probably due 
to a combination of multiple events rather than to deficit 
of a specific TET enzyme. Primarily, as 5hmC formation 
requires 5mC as initial substrate, which also undergoes 
reduction with aging, the decrease in 5hmC might reflect 
defective 5mC levels. Furthermore, 5hmC accumulation 
also depends on additional iterative oxidation reactions 
mediated by TET enzymes themselves. Thus, the 
impairment of TET hydroxylase activity by post-
translational modification [46,47], together with the 
availability of their cofactors, such as ascorbate [48] or 2-
oxoglutarate [49], may represent additional mechanisms 
able to impact 5hmC formation in aging. 
 
The analysis of DNA demethylation intermediates in 
PBMC evidenced that 5hmC reduction in aged 
individuals coincided with increased of 5caC levels and 
almost unaltered content of 5fC. Evidence of 5hmC loss 
and 5caC accumulation has recently been described in 
human breast cancers and gliomas [50]. Although the 
conversion rate of 5hmC into 5fC/5caC is 5-10-fold 
lower than the one of 5mC into 5hmC [15], a modest 
impact of 5hmC oxidations could account for its 
reduction in aging. This is remarkable if one considers 
that 5fC and 5caC are also stable DNA modifications 
with their own transcriptional/epigenetic functions 
[51,52]. The production of 5caC, in presence of reduced 
TET1 and TET3 expression in aging, may depend on 
TET2, whose expression was particularly high 
compared to the other members of the family and 
independent of aging. Consistently, several reports 
demonstrated the ability of TET2 to yield 5caC and to 
convert 5mC-containing DNA into 5caC also without 
release of the 5hmC intermediate [53]. On the other 
hand, the persistence of 5caC in aging could depend on 
TDG down-regulation or on the impairment of the 
TDG-BER activity. Notably, TET1 interacts with TDG 
and stabilizes its activity enhancing the TDG-dependent 
excision of 5caC [54]. Hence the decrease of TET1 in 
aging could contribute to 5caC accumulation in addition 
to 5hmC decline. Moreover, it is to be considered that 
the decrease of TET1 and TET3 gene expression in 
aging may have additional outcomes besides their 
contribution to the 5hmC/5fC/5caC levels. In fact, TET 
enzymes also exhibit non-catalytic functions in 
transcriptional regulation and DNA repair [42,54,55]. 
 
The above-mentioned interplay between TDG and TET1 
was supported by the observed highly significant 
positive correlation of their transcripts. Further, TET1 
strongly correlated with DNMT1 and DNMT3B 
transcript levels, which have recently been reported to 
undergo age-related deregulation in PBMC [10]. TET1 
expression was also linked to PARP1 and PARP2 gene 
expression. PARPs are the main enzymes involved in 
poly(ADP-ribosylation), which has been implicated in 
aging [56] and in the control of epigenetic modifications 
of both histones and DNA [57–59]. In addition, PARP2 
and TDG, which are both involved in the BER pathway 
[45], showed an interesting association. These results 
suggest that genes belonging to DNA methylation/deme- 
thylation pathways may be co-regulated in immune 
cells and possibly in aging. Notably, alternative 
networks of gene correlations have been shown to 
characterize aging and disease states as well, which may 
reflect an aberrant function of common transcriptional 
controllers [60–62]. 
 
Age-related alteration of the immune system contributes 
to increased susceptibility to infections, autoimmune 
diseases and cancer in the elderly [63]. In this context, 
the deregulation of TET expression and 5hmC 
formation in PBMC may impair the immune cell 
functionality in aging. In particular, TET2 is an 
ascertained gatekeeper of normal hematopoiesis [64] 
and inflammatory response [42], while the contribution 
of TET1 in immunity has only recently been reported. 
TET1 shows a differential expression during T-cell 
maturation [65] and mediates the transcriptional 
inhibition of the pro-inflammatory cytokine Interleukin-
1β [66]. More importantly, TET1 contributes to the 
lineage determination of regulatory T-cells, which are 
necessary for immune homeostasis by suppressing 
inflammatory responses [67]. 
 
In conclusion, this study examined for the first time the 
age-associated expression of TET1-3 and TDG genes as 
well as the content of 5hmC and its derivatives in 
PBMC deriving from the MARK-AGE study, 
representing a large cross-sectional European 
population. The enrolment of individuals from eight 
different European countries with typical climatic and 
dietary differences has permitted to monitor the 
influence of diverse environmental variables. However, 
although the environment represents one of the most 
significant modifiers of epigenetics [8], it had limited 
relevance for the parameters investigated, suggesting 
that the deregulation of 5hmC and TET genes is an 
inherent feature of aging. Furthermore, the age-
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dependent decline of TET1, TET3 and TDG in 
association with the decrease of 5hmC and the 
accumulation of 5caC points out an even more intricate 
epigenetic landscape in PBMC with aging. All these 
events could have epigenetic and transcriptional 
consequences that contribute to change DNA 
methylation patterns and immunological competence in 
aged individuals. 
 
MATERIALS AND METHODS 
 
Study population, recruitment, data and blood 
collection 
 
PBMC samples used in the present work derived from 
donors aged 34-74 years that have been recruited in the 
context of the MARK-AGE project [21,22]. The PBMC 
isolation procedure, details of the recruitment procedure 
and of the collection of anthropometric, clinical and 
demographic data have been published [68,69]. 
 
Briefly, PBMCs deriving from donors of eight European 
countries were isolated from EDTA-whole blood, 
obtained by phlebotomy after an overnight fasting, by 
discontinuous density gradient centrifugation in Percoll 
and subsequently cryopreserved, stored in liquid nitrogen 
and then shipped to the MARK-AGE Biobank located at 
the University of Hohenheim, Stuttgart, Germany. From 
the Biobank, coded samples were subsequently sent to 
the Sapienza University of Rome on dry ice, where they 
were stored in liquid nitrogen. 
 
RNA extraction and cDNA synthesis 
 
Samples were thawed by incubation at 37°C, followed 
by dropwise addition of RPMI containing 10% FCS to a 
final dilution of 1:20. Cells were collected by 
centrifugation and processed for RNA extraction by 
using RNeasy Mini Kit (Qiagen) according to the 
manufacturer's instructions and subjected to DNase I 
digestion using RNase-free DNase (Qiagen). RNA 
concentration, purity and integrity were evaluated as 
previously described [70]. Reverse transcription was 
carried out using the SuperScript VILO cDNA 
Synthesis Kit (Invitrogen) on equal amounts of total 
RNA (0.5 μg). 
 
Real-time quantitative RT-PCR 
 
The expression of TET1, TET2, TET3 and TDG was 
determined by quantitative PCR using Taqman Gene 
Expression Assays (Applied Biosystems) following the 
manufacturer's protocol on the iCycler IQ detection 
system (Bio-Rad). Each set of primers and probe 
showed an efficiency of 90–100%. Assays were 
performed in duplicate with cDNA equivalent to 30 ng 
of reverse transcribed RNA. Gene expression analysis 
was performed by the relative calibrator normalized 
quantification method using the expression level of the 
β-glucuronidase gene (GUSB) as reference [70]. An 
inter-run calibration sample was used in all plates to 
correct for the technical variance between the different 
runs and to compare results from different plates. The 
calibrator consisted of cDNA prepared from HEK293T 
cells. Taqman Gene Expression Assays IDs for each set 
of primers and probe were as follows: Hs00286756_m1 
(TET1); Hs00758658_m1 (TET2); Hs00379125_m1 
(TET3); Hs00702322_s1 (TDG); Hs99999908_m1 
(GUSB). 
 
Dot blot assay 
 
DNA was extracted from PBMC with DNeasy Blood & 
Tissue Kit (QIAGEN), samples denatured in 0.4 M 
NaOH, 10 mM EDTA at 95°C for 10 min, and then 
neutralized by adding an equal volume of ice-cold 4 M 
ammonium acetate (pH 7.0). Two-fold dilutions of 
DNA samples were spotted on a nitrocellulose 
membrane Hybond-N+ (Amersham Biosciences) in an 
assembled Bio-Dot apparatus (Bio-Rad). After vacuum-
associated blotting procedure, the membrane was 
washed with 2X SSC buffer, air-dried and blocked with 
5% non-fat milk followed by incubation with primary 
polyclonal anti-5hmC, 5fC, or 5caC antibodies (Active 
Motif). By the use of HRP-conjugated secondary 
antibodies, signals were visualized by chemilumine-
scence (Amersham ECL Western Blotting detection 
reagents). A total of 250 ng of DNA was used for 5hmC 
detection, while 750 ng of DNA for 5fC and 5caC. The 
same amount of DNA from multiple samples was 
pooled into different groups of increasing age for the 
analysis of 5fC and 5caC levels. To correct for technical 
variance between replicates and to compare results from 
different experiments, a control DNA deriving from 
HEK293T cells was used in all assays. To monitor 
DNA loading, filters were stained with 0.02% 
methylene blue (MB) in 0.3 M sodium acetate (pH 5.2). 
Densitometric analysis was performed by Quantity One 
Software (Bio-Rad Laboratories) according to 
manufacturer’s instructions. To evaluate the specificity 
of antibodies, 5mC and 5hmC DNA Standard Set 
(Zymo Research) was used together with DNA derived 
from HEK293T cells overexpressing the catalytic 
domain of TET1 (OE TET1). 
 
EpiTYPER assay for quantitative DNA methylation 
analysis 
 
The EpiTYPER assay (Sequenom) was used to 
quantitatively assess the DNA methylation state of 
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TET1 and TDG CGIs and TET1 3’-shore. DNA (1 μg) 
was bisulfite-converted using the EZ-96 DNA 
Methylation Kit (Zymo Research) with the following 
modifications: Incubation in CT buffer was performed 
for 21 cycles of 15 min at 55°C and 30 sec at 95°C and 
elution of bisulfite-treated DNA was performed in 100 
μl of water. PCR was performed on 10 ng of bisulfite-
treated DNA using specific primers. The TET1 CGIs 
and TET1 3’-shore amplicons mapped in 
chr10:70,320,251-70,320,466 and chr10:70,321,719-
70,322,204 (GRCh37/hg19) regions, respectively. TDG 
amplicon mapped in chr12:104,359,220-104,359,701 
(GRCh37/hg19) region. 









TET1 CGI_Reverse:  
cagtaatacgactcactataGGGAGAAGGCTATCATACAA
CCCTACCTACCTCTCC 








Distribution of TET1, TET2, TET3, TDG and 5hmC 
variables was investigated Kolmogorov-Smirnov and 
Shapiro-Wilk normality tests. Identification of potential 
critical variables that can affect TET1, TET2, TET3, 
TDG mRNAs and 5hmC levels in PBMCs was 
performed by non-parametric tests (Kruskal-Wallis test 
or Mann-Whitney U test for two group comparisons) as 
well as by Generalized Linear Models (GLM). Pairwise 
comparisons (adjusted for multiple comparisons by 
Dunn's and Bonferroni’s methods for the Kruskal-
Wallis and the GLM tests, respectively) were used to 
identify significant differences between percentile 
groups of each categorized variables. 
 
Influence of age and the relative impact of confounding 
variables on analyzed parameters, was investigated by 
linear regression and also by stratified bootstrap 
sampling (1000 bootstrap samples). GLM were used to 
investigate the influence of confounding variables 
(tested as categorized and continuous variables) on age-
related changes of analyzed parameters. The Bonferroni 
adjustment for multiple comparisons was used to 
identify differences between subgroups. 
 
The identification of the major variables affecting TET2 
mRNA in PBMCs was performed using decision tree 
analysis with exhaustive "Chi-squared Automatic 
Interaction Detector" (CHAID) algorithms. To 
determine the best split at any node, the CHAID 
algorithm chooses the predictor variable with the 
smallest adjusted p-value, i.e., the predictor variable 
that will yield the most significant split. If the smallest 
(Bonferroni) adjusted p-value for any predictor is 
greater than some alpha-to-split value, then no further 
splits are performed, and the respective node is a 
terminal node. The process repeats recursively until one 
of the stopping rules is triggered. In growing the tree the 
following stopping rules were used: minimum terminal 
parental node size of 20 cases, minimum terminal child 
node size of 10 cases and alpha = 0.05 for splitting 
nodes. The convergence criteria for the Exhaustive 
CHAID were: epsilon = 0.001 and 100 as the maximum 
number of iterations before stopping the process. 
 
The potential influence of batch effects was investigated 
by correcting batch effects with the Partek Genomic 
Suite 6.6 implemented with the ANOVA tool (Partek 
Incorporated) using log-transformed variables. We 
considered each real-time PCR plate (containing 8 
samples with study groups not evenly distributed across 
plates) as a batch. We performed adjustments for 
batches by applying the following strategies: (i) simple 
removal of batch effect (including PCR plates as 
batches in the ANOVA tool); (ii) removal of batch 
effects attempting to retain differences in age and 
gender (identified as variable of interest in the ANOVA 
tool). The same analysis was conducted using log-
transformed variables of 5hmC. We considered each 
dot-blot filter (containing 19 samples with study groups 
not evenly distributed across plates) as a batch. 
 
All statistical analysis (excluding analysis of batch 
effects) was carried out using SPSS software (SPSS 
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